The $15 billion ad-powered AI startup your doctor may already be using
OpenEvidence is booming despite questions about accuracy and ads.
OpenEvidence is booming despite questions about accuracy and ads.
The short version
- Nearly two-thirds of US doctors are turning to an AI-powered search engine to make patient decisions, propelling a little-known tech startup to a $15 billion valuation while prompting a debate over the future of patient care.
- Miami-based OpenEvidence, founded by serial entrepreneur Daniel Nadler in 2022, said that many of America’s 1 million physicians processed more than 42 million prompts last month.
- Doctors are using the company’s chatbot to scour medical journals and clinical guidelines to help diagnose and treat patients.
What happened
The ads-powered platform has grown largely by word of mouth, penetrating a sector where few tools have seen similar traction. “We’re the first viral consumer internet app in healthcare,” Nadler told the FT in an interview.
Why it matters
OpenEvidence has won praise from medical professionals who have found it helped ease workloads, according to interviews with eight senior physicians.
Summary by Nerd News Network. Read the full article at Ars Technica via the links above and below.